SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-042947
Filing Date
2024-05-14
Accepted
2024-05-14 16:15:22
Documents
7
Period of Report
2024-05-14

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0205985-6k_chinasxt.htm 6-K 28977
2 FORM OF SECURITIES PURCHASE AGREEMENT DATED MAY 9, 2024 ea020598501ex10-1_china.htm EX-10.1 127771
3 FORM OF SECURITIES PURCHASE AGREEMENT DATED MARCH 27, 2024 ea020598501ex10-2_china.htm EX-10.2 127780
4 FORM OF SECURITIES PURCHASE AGREEMENT DATED DECEMBER 13, 2023 ea020598501ex10-3_china.htm EX-10.3 128921
5 FORM OF CONVERTIBLE PROMISSORY NOTE DATED MAY 9, 2024 ea020598501ex10-4_china.htm EX-10.4 100756
6 FORM OF CONVERTIBLE PROMISSORY NOTE DATED MARCH 27, 2024 ea020598501ex10-5_china.htm EX-10.5 101223
7 FORM OF CONVERTIBLE PROMISSORY NOTE DATED DECEMBER 13, 2023 ea020598501ex10-6_china.htm EX-10.6 101238
  Complete submission text file 0001213900-24-042947.txt   717700
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38773 | Film No.: 24944535
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)